IP Library › Granted Patent US 12,462,006
Granted Patent B2
US 12,462,006 · App. 17/944,976 · Granted Nov 4, 2025

Modular analyte connectivity system for extendible communication with different types of physiological sensors

Inventors: Nikhil Desai (San Francisco, CA); Justin Williams (Oakland, CA)
Assignee: ABBOTT DIABETES CARE INC.
G06F21/32A61B5/14532G16H10/60G16H40/63A61B5/14503A61B5/14546A61B2560/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,462,006
App. No.
17/944,976
Granted
Nov 4, 2025
Kind
B2
Abstract

A medical device communication system with a modular design to communicate with different types of medical devices, such as physiological sensors. The modular design is implemented using an extensible software library that provides a uniform framework for various applications or third party applications access to medical device data. The modular design also allows for regulated and unregulated portions of the system to be integrated into the system while allowing each portion to be updated separately. The regulated portion of the system may include components, such as sensors and the software library, that are subject to regulatory approval while the unregulated portion may include applications that are not subject to regulatory approval. Thus, the system enables a third party application developer to avoid having to submit the application to a regulatory agency for an application making use of the sensor data.

Claims (53)

1 . A method for relaying analyte data from a physiological sensor to at least one application via a physiological sensor framework module, the method comprising:

receiving a bind request to bind a physiological sensor plug-in associated with a type of physiological sensor to a core framework in the physiological sensor framework module, wherein the physiological sensor plug-in is included in a software library that is subject to regulatory approval as a medical device;

performing, responsive to the bind request, an authentication of the physiological sensor plug-in;

binding, responsive to the authentication, the physiological sensor plug-in to the core framework; and

relaying, responsive to binding the physiological sensor plug-in, analyte data from the physiological sensor to the at least one application, wherein the at least one application is not subject to regulatory approval.

2 . The method of claim 1 , wherein the physiological sensor is a dual-channel physiological sensor.

3 . The method of claim 1 , wherein the physiological sensor is a physical sensor.

4 . The method of claim 1 , wherein the physiological sensor is a virtual sensor.

5 . The method of claim 1 , further comprising:

providing, responsive to the binding, an application programming interface to the at least one application, wherein the application programming interface is configured to expose at least one function for controlling the physiological sensor via the physiological sensor plug-in.

6 . The method of claim 1 , wherein the physiological sensor comprises any one of a glucose sensor, lactate sensor, or ketone sensor.

7 . The method of claim 1 , further comprising:

receiving a second bind request to bind a second physiological sensor plug-in associated with a second type of a second physiological sensor to the core framework in the physiological sensor framework module, wherein the second type of the second physiological sensor is different from the type of the physiological sensor, and the second physiological sensor plug-in is included in the software library;

performing, responsive to the second bind request, a second authentication of the second physiological sensor plug-in;

binding, responsive to the second authentication, the second physiological sensor plug-in to the core framework; and

relaying, responsive to binding the second physiological sensor plug-in, second analyte data from the second physiological sensor to the at least one application, wherein the second analyte data corresponds to a second analyte that is different from a first analyte corresponding to the analyte data.

8 . The method of claim 1 , further comprising:

generate, responsive to binding the physiological sensor plug-in, an object instance associated with the physiological sensor, wherein the object instance comprises a plurality of attributes associated with the physiological sensor.

9 . A physiological sensor framework module comprising:

a user interface module configured to communicate user interface information to at least one physiological sensor application; and

an analyte device connectivity system comprising:

a physiological sensor plug-in configured to relay communications between a physiological sensor and the at least one physiological sensor application, wherein:

the physiological sensor plug-in is associated with a type of physiological sensor, includes a set of sensor-specific commands for communicating with the physiological sensor, and is included in a software library that is subject to regulatory approval as a medical device, and

the at least one physiological sensor application is not subject to regulatory approval; and

a core framework configured to:

receive a bind request to bind the physiological sensor plug-in to the core framework;

perform, responsive to the bind request, an authentication of the physiological sensor plug-in;

bind, responsive to the authentication, the physiological sensor plug-in to the core framework; and

relay, responsive to binding the physiological sensor plug-in, analyte data from the physiological sensor to the at least one physiological sensor application.

10 . The physiological sensor framework module of claim 9 , wherein the physiological sensor is a dual-channel physiological sensor.

11 . The physiological sensor framework module of claim 9 , wherein the physiological sensor is a physical sensor.

12 . The physiological sensor framework module of claim 9 , wherein the physiological sensor is a virtual sensor.

13 . The physiological sensor framework module of claim 9 , wherein the core framework is further configured to:

generate, responsive to binding the physiological sensor plug-in, an object instance associated with the physiological sensor, wherein the object instance comprises a plurality of attributes associated with the physiological sensor.

14 . The physiological sensor framework module of claim 13 , wherein the plurality of attributes comprises at least one of: a glucose concentration attribute, a sensor calibration attribute, a sensor run-time attribute, a glucose sampling interval attribute, and a glucose trend attribute.

15 . The physiological sensor framework module of claim 13 , wherein the plurality of attributes comprises a mandatory attribute, a conditional attribute, a recommended attribute, a non-recommended attribute, and an optional attribute.

16 . A physiological sensor and communication interface comprising:

an on-body unit configured to attach to a body of a user and comprising at least two physiological sensors, each of the at least two physiological sensors configured to generate data including data indicative of a different physiological signal; and

a non-transitory computer-readable storage medium storing a software library configured to be executed by one or more processors of a computing device, wherein the software library is subject to regulatory approval as a medical device, wherein the software library comprises a sensor control module including instructions to:

bind a first physiological sensor plug-in associated with a first type of physiological sensor to a core framework in the sensor control module, the first physiological sensor plug-in including a first set of sensor-specific commands for communicating with a first physiological sensor of the at least two physiological sensors;

bind a second physiological sensor plug-in associated with a second type of physiological sensor to the core framework, the second physiological sensor plug-in including a second set of sensor-specific commands for communicating with a second physiological sensor of the at least two physiological sensors, wherein the second type of physiological sensor is different from the first type of physiological sensor, and the second set of sensor-specific commands is different from the first set of sensor-specific commands;

authenticate the computing device with the on-body unit,

enable a communication session with the on-body unit to substantially simultaneously receive the data from each of the at least two physiological sensors,

store the data acquired from each of the at least two physiological sensors in a memory of the computing device,

obtain an output indicative of the physiological signal from the data of each of the at least two physiological sensors, and

provide the output indicative of the different physiological signal from each of the at least two physiological sensors to an authenticated third-party application running on the computing device, wherein the authenticated third-party application is not subject to regulatory approval.

17 . The physiological sensor and communication interface of claim 16 , wherein the at least two physiological sensors comprise at least two analyte sensors configured to detect different types of analyte levels.

18 . The physiological sensor and communication interface of claim 16 , wherein the data acquired from at least one of the at least two physiological sensors is subject to regulatory approval.

19 . The physiological sensor and communication interface of claim 16 , wherein the at least two physiological sensors comprise any one or more of a glucose sensor, lactate sensor, or ketone sensor.

20 . The physiological sensor and communication interface of claim 16 , wherein at least one of the at least two physiological sensors is a glucose sensor and wherein the output indicative of the physiological signal further comprises a glucose trend, historical glucose data, time in range of target glucose, or a glucose system alert.

21 . The method of claim 7 , wherein:

relaying the analyte data from the physiological sensor to the at least one application comprises relaying the analyte data to a first application; and

relaying the second analyte data from the second physiological sensor to the at least one application comprises relaying the analyte data to a second application.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2023
From: DESAI, NIKHIL; WILLIAMS, JUSTIN
To: ABBOTT DIABETES CARE INC.
Reel/Frame 062737/0293 →
Continuity (4)
Provisional Application 63316906 · Mar 4, 2022
Provisional Application 63295726 · Dec 31, 2021
Provisional Application 63244694 · Sep 15, 2021
Related Publication 20230083633A1 · Mar 16, 2023
References Cited (400)
US 4561443A · Hogrefe et al. · 1985 [cited by applicant]
US 5390671A · Lord et al. · 1995 [cited by applicant]
US 5391250A · Cheney, II et al. · 1995 [cited by applicant]
US 5482473A · Lord et al. · 1996 [cited by applicant]
US 5660163A · Schulman et al. · 1997 [cited by applicant]
US 5690119A · Rytky et al. · 1997 [cited by applicant]
US 5899855A · Brwon · 1999 [cited by applicant]
US 5954643A · VanAntwerp et al. · 1999 [cited by applicant]
US 6096268A · Inbar · 2000 [cited by applicant]
US 6134461A · Say et al. · 2000 [cited by applicant]
US 6159181A · Crossman et al. · 2000 [cited by applicant]
US 6175752B1 · Say et al. · 2001 [cited by applicant]
US 6266551B1 · Osadchy et al. · 2001 [cited by applicant]
US 6270455B1 · Brown · 2001 [cited by applicant]
US 6293925B1 · Safabash et al. · 2001 [cited by applicant]
US 6298255B1 · Cordero et al. · 2001 [cited by applicant]
US 6424847B1 · Mastrototaro et al. · 2002 [cited by applicant]
US 6424874B1 · Mastrototaro et al. · 2002 [cited by applicant]
US 6560471B1 · Heller et al. · 2003 [cited by applicant]
US 6565509B1 · Say et al. · 2003 [cited by applicant]
US 6579690B1 · Bonnecaze et al. · 2003 [cited by applicant]
US 6600997B2 · Deweese et al. · 2003 [cited by applicant]
US 6641533B2 · Causey, III et al. · 2003 [cited by applicant]
US 6689056B1 · Kilcoyne et al. · 2004 [cited by applicant]
US 6695860B1 · Ward et al. · 2004 [cited by applicant]
US 6746582B2 · Heller et al. · 2004 [cited by applicant]
US 6749740B2 · Liamos et al. · 2004 [cited by applicant]
US 6809653B1 · Mann et al. · 2004 [cited by applicant]
US 6942518B2 · Liamos et al. · 2005 [cited by applicant]
US 7098803B2 · Mann et al. · 2006 [cited by applicant]
US 7299082B2 · Feldman et al. · 2007 [cited by applicant]
US 7324012B2 · Mann et al. · 2008 [cited by applicant]
US 7344500B2 · Talbot et al. · 2008 [cited by applicant]
US 7643798B2 · Ljung · 2010 [cited by applicant]
US 7693485B2 · Parys · 2010 [cited by applicant]
US 8401194B2 · Nierzwick et al. · 2013 [cited by applicant]
US 8764651B2 · Tran · 2014 [cited by applicant]
US 8771183B2 · Sloan · 2014 [cited by applicant]
US 8864651B2 · Kuyava et al. · 2014 [cited by applicant]
US 9000914B2 · Baker et al. · 2015 [cited by applicant]
US 9211065B2 · Marsh et al. · 2015 [cited by applicant]
US 9241631B2 · Valdes et al. · 2016 [cited by applicant]
US 9344777B2 · He et al. · 2016 [cited by applicant]
US 9577934B2 · Gross · 2017 [cited by applicant]
US 9980140B1 · Spencer et al. · 2018 [cited by applicant]
US 9996668B2 · Reihman et al. · 2018 [cited by applicant]
US 10085640B2 · Mensinger et al. · 2018 [cited by applicant]
US 10375222B2 · Mandapaka et al. · 2019 [cited by applicant]
US 10827954B2 · Hoss et al. · 2020 [cited by applicant]
US 10945647B2 · Mazza et al. · 2021 [cited by applicant]
US 10973443B2 · Funderburk et al. · 2021 [cited by applicant]
US 10980461B2 · Simpson et al. · 2021 [cited by applicant]
US 11000213B2 · Kamath et al. · 2021 [cited by applicant]
US 11064917B2 · Simpson et al. · 2021 [cited by applicant]
US 11116431B1 · Harper · 2021 [cited by applicant]
US 11141084B2 · Funderburk et al. · 2021 [cited by applicant]
US 11298056B2 · Harper · 2022 [cited by applicant]
US 11991175B2 · Rolfe et al. · 2024 [cited by applicant]
US 20020109621A1 · Khair et al. · 2002 [cited by applicant]
US 20030050009A1 · Kurisko et al. · 2003 [cited by applicant]
US 20030065536A1 · Hansen et al. · 2003 [cited by applicant]
US 20030100821A1 · Heller et al. · 2003 [cited by applicant]
US 20030144581A1 · Conn et al. · 2003 [cited by applicant]
US 20030153900A1 · Aceti et al. · 2003 [cited by applicant]
US 20030208113A1 · Mault et al. · 2003 [cited by applicant]
US 20040106860A1 · Say et al. · 2004 [cited by applicant]
US 20040117204A1 · Mazar et al. · 2004 [cited by applicant]
US 20040122353A1 · Shahmirian et al. · 2004 [cited by applicant]
US 20040127958A1 · Mazar et al. · 2004 [cited by applicant]
US 20040133164A1 · Funderburk et al. · 2004 [cited by applicant]
US 20040186365A1 · Jin et al. · 2004 [cited by applicant]
US 20040193025A1 · Steil et al. · 2004 [cited by applicant]
US 20050027463A1 · Goode, Jr. et al. · 2005 [cited by applicant]
US 20050049501A1 · Conero et al. · 2005 [cited by applicant]
US 20050101912A1 · Faust et al. · 2005 [cited by applicant]
US 20050177398A1 · Watanabe et al. · 2005 [cited by applicant]
US 20050182306A1 · Sloan · 2005 [cited by applicant]
US 20050204134A1 · Von Arx et al. · 2005 [cited by applicant]
US 20050240245A1 · Bange et al. · 2005 [cited by applicant]
US 20050242479A1 · Petisce et al. · 2005 [cited by applicant]
US 20050261563A1 · Zhou et al. · 2005 [cited by applicant]
US 20050283114A1 · Bresina et al. · 2005 [cited by applicant]
US 20060016700A1 · Brister et al. · 2006 [cited by applicant]
US 20060019327A1 · Brister et al. · 2006 [cited by applicant]
US 20060025663A1 · Talbot et al. · 2006 [cited by applicant]
US 20060081469A1 · Lee · 2006 [cited by applicant]
US 20060202859A1 · Mastrototaro et al. · 2006 [cited by applicant]
US 20060224109A1 · Steil et al. · 2006 [cited by applicant]
US 20070038044A1 · Dobbles et al. · 2007 [cited by applicant]
US 20070043279A1 · Mannheimer et al. · 2007 [cited by applicant]
US 20070060801A1 · Neinast · 2007 [cited by applicant]
US 20070073129A1 · Shah et al. · 2007 [cited by applicant]
US 20070093786A1 · Goldsmith et al. · 2007 [cited by applicant]
US 20070142727A1 · Zhang et al. · 2007 [cited by applicant]
US 20070173708A9 · Dobbles et al. · 2007 [cited by applicant]
US 20070173710A1 · Petisce et al. · 2007 [cited by applicant]
US 20070219480A1 · Kamen et al. · 2007 [cited by applicant]
US 20070255116A1 · Mehta et al. · 2007 [cited by applicant]
US 20070288265A1 · Quinian et al. · 2007 [cited by applicant]
US 20080009805A1 · Ethelfeld · 2008 [cited by applicant]
US 20080081977A1 · Hayter et al. · 2008 [cited by applicant]
US 20080092638A1 · Brenneman et al. · 2008 [cited by applicant]
US 20080097246A1 · Stafford · 2008 [cited by applicant]
US 20080119705A1 · Patel et al. · 2008 [cited by applicant]
US 20080129486A1 · Jeckelmann et al. · 2008 [cited by applicant]
US 20080161666A1 · Feldman et al. · 2008 [cited by applicant]
US 20080172205A1 · Breton et al. · 2008 [cited by applicant]
US 20080214900A1 · Fennell et al. · 2008 [cited by applicant]
US 20080228045A1 · Gao et al. · 2008 [cited by applicant]
US 20080269687A1 · Chong et al. · 2008 [cited by applicant]
US 20080275313A1 · Brister et al. · 2008 [cited by applicant]
US 20080278333A1 · Fennell et al. · 2008 [cited by applicant]
US 20080300476A1 · Stafford · 2008 [cited by applicant]
US 20080312512A1 · Brukalo et al. · 2008 [cited by applicant]
US 20080319414A1 · Yodfat et al. · 2008 [cited by applicant]
US 20090018424A1 · Kamath et al. · 2009 [cited by applicant]
US 20090033482A1 · Hayter et al. · 2009 [cited by applicant]
US 20090033485A1 · Hayter et al. · 2009 [cited by applicant]
US 20090054748A1 · Feldman · 2009 [cited by applicant]
US 20090085768A1 · Patel et al. · 2009 [cited by applicant]
US 20090112626A1 · Talbot et al. · 2009 [cited by applicant]
US 20090198118A1 · Hayter et al. · 2009 [cited by applicant]
US 20090240193A1 · Mensinger et al. · 2009 [cited by applicant]
US 20090247857A1 · Harper et al. · 2009 [cited by applicant]
US 20100014626A1 · Fennell et al. · 2010 [cited by applicant]
US 20100045425A1 · Chivallier · 2010 [cited by applicant]
US 20100198034A1 · Thomas et al. · 2010 [cited by applicant]
US 20100198142A1 · Sloan et al. · 2010 [cited by applicant]
US 20100213057A1 · Feldman et al. · 2010 [cited by applicant]
US 20100230285A1 · Hoss et al. · 2010 [cited by applicant]
US 20100274218A1 · Yodfat et al. · 2010 [cited by applicant]
US 20100302979A1 · Reunamäki · 2010 [cited by applicant]
US 20100327063A1 · Medina et al. · 2010 [cited by applicant]
US 20110002223A1 · Gross · 2011 [cited by applicant]
US 20110125000A1 · Rantala · 2011 [cited by applicant]
US 20110177780A1 · Sato et al. · 2011 [cited by applicant]
US 20110193704A1 · Harper et al. · 2011 [cited by applicant]
US 20110213225A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110282671A1 · Dicks et al. · 2011 [cited by applicant]
US 20110320130A1 · Valdes et al. · 2011 [cited by applicant]
US 20120003933A1 · Baker et al. · 2012 [cited by applicant]
US 20120078071A1 · Bohm et al. · 2012 [cited by applicant]
US 20120108931A1 · Taub et al. · 2012 [cited by applicant]
US 20120123227A1 · Sun et al. · 2012 [cited by applicant]
US 20120182917A1 · Edlund · 2012 [cited by applicant]
US 20120237022A1 · Berson et al. · 2012 [cited by applicant]
US 20120255875A1 · Vicente et al. · 2012 [cited by applicant]
US 20120260323A1 · San Vicente et al. · 2012 [cited by applicant]
US 20120265035A1 · Bohm et al. · 2012 [cited by applicant]
US 20130078912A1 · San Vicente et al. · 2013 [cited by applicant]
US 20130127627A1 · Hayter et al. · 2013 [cited by applicant]
US 20130150691A1 · Pace et al. · 2013 [cited by applicant]
US 20130310896A1 · Mass · 2013 [cited by applicant]
US 20140171771A1 · Feldman et al. · 2014 [cited by applicant]
US 20140176338A1 · He et al. · 2014 [cited by applicant]
US 20140266776A1 · Miller et al. · 2014 [cited by applicant]
US 20140266785A1 · Miller et al. · 2014 [cited by applicant]
US 20140273858A1 · Panther et al. · 2014 [cited by applicant]
US 20140313052A1 · Yarger et al. · 2014 [cited by applicant]
US 20140350883A1 · Carter et al. · 2014 [cited by applicant]
US 20140379273A1 · Petisce et al. · 2014 [cited by applicant]
US 20150038818A1 · Cole · 2015 [cited by applicant]
US 20150089222A1 · White et al. · 2015 [cited by applicant]
US 20150118658A1 · Mayou et al. · 2015 [cited by applicant]
US 20150123810A1 · Hernandez-Rosas et al. · 2015 [cited by applicant]
US 20150164391A1 · Hernandez-Rosas et al. · 2015 [cited by applicant]
US 20150205947A1 · Berman · 2015 [cited by examiner]
US 20150207796A1 · Love et al. · 2015 [cited by applicant]
US 20150289124A1 · Palin et al. · 2015 [cited by applicant]
US 20160066826A1 · Larvenz et al. · 2016 [cited by applicant]
US 20160081597A1 · Bhavaraju et al. · 2016 [cited by applicant]
US 20160165649A1 · Polo et al. · 2016 [cited by applicant]
US 20160210099A1 · Hampapuram et al. · 2016 [cited by applicant]
US 20160234020A1 · Nix · 2016 [cited by applicant]
US 20160331283A1 · Rao et al. · 2016 [cited by applicant]
US 20170220745A1 · Lee et al. · 2017 [cited by applicant]
US 20180226150A1 · Hayter · 2018 [cited by examiner]
US 20180235520A1 · Rao et al. · 2018 [cited by applicant]
US 20190216373A1 · Harper · 2019 [cited by applicant]
US 20190274598A1 · Scott et al. · 2019 [cited by applicant]
US 20190349346A1 · Curtis et al. · 2019 [cited by applicant]
US 20200139140A1 · Crawford · 2020 [cited by applicant]
US 20200196919A1 · Rao et al. · 2020 [cited by applicant]
US 20200375455A1 · Van Tassel et al. · 2020 [cited by applicant]
EP 2407094 · 2012 [cited by applicant]
EP 3158922A1 · 2017 [cited by applicant]
EP 3240352A1 · 2017 [cited by applicant]
EP 3435866 · 2020 [cited by applicant]
EP 3730045 · 2022 [cited by applicant]
EP 3797685 · 2022 [cited by applicant]
WO WO9958190 · 1999 [cited by applicant]
WO WO0062664A1 · 2000 [cited by applicant]
WO WO0215778 · 2002 [cited by applicant]
WO WO03026728 · 2003 [cited by applicant]
WO WO03026728A1 · 2003 [cited by applicant]
WO WO2004006982 · 2004 [cited by applicant]
WO WO2005018450 · 2005 [cited by applicant]
WO WO2005046780 · 2005 [cited by applicant]
WO WO2005046780A1 · 2005 [cited by applicant]
WO WO2006040083 · 2006 [cited by applicant]
WO WO2006094513 · 2006 [cited by applicant]
WO WO2006121921 · 2006 [cited by applicant]
WO WO2006121921A2 · 2006 [cited by applicant]
WO WO2007002189A2 · 2007 [cited by applicant]
WO WO2007097754 · 2007 [cited by applicant]
WO WO2007104755A1 · 2007 [cited by applicant]
WO WO2008065646 · 2008 [cited by applicant]
WO WO2008065646A1 · 2008 [cited by applicant]
WO WO2008073813 · 2008 [cited by applicant]
WO WO2008114223 · 2008 [cited by applicant]
WO WO2008115409 · 2008 [cited by applicant]
WO WO2008144325A1 · 2008 [cited by applicant]
WO WO2008157821 · 2008 [cited by applicant]
WO WO2008157821A1 · 2008 [cited by applicant]
WO WO2009005952A2 · 2009 [cited by applicant]
WO WO2009007287 · 2009 [cited by applicant]
WO WO2009035773 · 2009 [cited by applicant]
WO WO2009039013 · 2009 [cited by applicant]
WO WO2009039013A1 · 2009 [cited by applicant]
WO WO2013044153A1 · 2013 [cited by applicant]
WO WO2013069894A1 · 2013 [cited by applicant]
WO WO2013090731A1 · 2013 [cited by applicant]
WO WO2013090791A1 · 2013 [cited by applicant]
WO WO2014011488A2 · 2014 [cited by applicant]
WO WO2014158405A2 · 2014 [cited by applicant]
WO WO2014165172A1 · 2014 [cited by applicant]
WO WO2014179343A1 · 2014 [cited by applicant]
WO WO2015069797A1 · 2015 [cited by applicant]
WO WO2016064184A1 · 2016 [cited by applicant]
WO WO2016092448A1 · 2016 [cited by applicant]
WO WO2016101774A1 · 2016 [cited by applicant]
WO WO2017172781A1 · 2017 [cited by applicant]
WO WO2018017484 · 2018 [cited by applicant]
WO WO2018075333A2 · 2018 [cited by applicant]
WO WO2018136898A1 · 2018 [cited by applicant]
WO WO2019236850A1 · 2019 [cited by applicant]
WO WO2019236859A1 · 2019 [cited by applicant]
WO WO2019236876A1 · 2019 [cited by applicant]
IEC 62304, ED. 1.1, Medical Device Software—Software Life Cycle Processes, 2015. [cited by applicant]
International Standard, ISO 13485, Medical devices Quality management systems—Requirements for regulatory purposes, 2016. [cited by applicant]
International Standard, ISO 14971, Medical devices—Application of risk management to medical devices, 2012, 97 pages. [cited by applicant]
Almurashi et al., “Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases,” J. Indian Inst. Sci, 2023, 27 pgs. [cited by applicant]
Atmel Datasheet for ATmega 169P, 2010, 198 pgs. (Part 1). [cited by applicant]
Atmel Datasheet for ATmega 169P, 2010, 198 pgs. (Part 2). [cited by applicant]
Cappon et al., “Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications,” Diabetes Metab J 43:383-397 (2019). [cited by applicant]
CDC National Diabetes Statistics Report, Nov. 29, 2023, 17 pgs. [cited by applicant]
Das et al., “Review—Electrochemistry and Other Emerging Technologies for Continuous Glucose Monitoring Devices,” ECS Sensors Plus 1:031601 (2022) 20 pgs. [cited by applicant]
Dexcom G5 Mobile CGM System User Guide 1, 2016, 186 pgs. [cited by applicant]
Dexcom G5 Mobile CGM System User Guide 2, 2016, 187 pgs. [cited by applicant]
Dexcom G6 CGM Users Guide, 2022, 347 pgs., Revised Nov. 2022. [cited by applicant]
Dexcom G6 CGM Users Guide, 2022, 347 pgs., Revised Mar. 2022. [cited by applicant]
Dexcom Seven Plus Users Guide, 2010, 145 pgs. [cited by applicant]
DXCM STS-7 CGM User Guide FCC Submission, 2006, 4 pgs. [cited by applicant]
Freestyle Libre 3 Users Manual, 2023, 249 pgs. [cited by applicant]
Freestyle Navigator Users Guide, 2008, 197 pgs. [cited by applicant]
Garg et al., “Flash Glucose Monitoring: The Future Is Here,” Diabetes Technology & Therapeutics 19(2):S1-S3 (2017). [cited by applicant]
Gomez et al., “Overview and Evaluation of Bluetooth Low Energy: An Emerging Low-Power Wireless Technology,” Sensors 12:11734-11753 (2012). [cited by applicant]
Hirsch et al., Role of Continuous Glucose Monitoring in Diabetes Treatment, 2018, 29 pgs. [cited by applicant]
MiniMed Paradigm Insulin Pump User Guide, 2007, 181 pgs. [cited by applicant]
Morak et al., “Design and Evaluation of a Telemonitoring Concept Based on NFC-Enabled Mobile Phones and Sensor Devices,” IEEE Transactions on Information Technology in Biomedicine, Nov. 2011, 8 pgs. [cited by applicant]
Padgette et al., “Guide to Bluetooth Security. Recommendations of the National Institute of Standards and Technology,” NIST Special Publication 800-121, Revision 1, Jun. 2012, 47 pgs. [cited by applicant]
Winter 2008, Atmel Product Guide, 91 pgs. [cited by applicant]
U.S. Appl. No. 60/614,683, filed Sep. 30, 2004, Brister, et al. [cited by applicant]
“Setting Your Sensor Settings” retrieved from “https://web.archive.org/web/20160803065621/http://www.medtronicdiabetes.com:80/customer-support/device-settings-and-features/sensor-settings/setting-sensor-settings” on Nov… [cited by applicant]
Dexcom G5 Mobile Continuous Glucose Monitoring System, Advisory Committee Briefing Materials, Clinical Chemistry and Clinical Toxicology Devices Panel, 283 pages (2016). [cited by applicant]
Dowla, “The Basics of Radio Frequency Identification (RFID) Technology”, Handbook of RF & Wireless Technologies, Chapter 14, 44 pages (2004). [cited by applicant]
Evans, et al., “Clinical temperature acquisition using proximity telemetry”, J. Biomed. Eng., 13:83-86 (1991). [cited by applicant]
Finkenzeller, “RFID Handbook: Fundamentals and Applications in Contactless Smart Cards and Identification”, Second Edition, 114 pages (2003). [cited by applicant]
Heller, et al., “Electrochemical Glucose Sensors and Their Applications in Diabetes Management”, Chemical Reviews, 108(7):2482-2505 (2008). [cited by applicant]
Lee, “RFID Coil Design”, Microchip Technology Inc., DS00678B, pp. 1-19 (1998). [cited by applicant]
Liang, et al., “An implantable bi-directional wireless transmission system for transcutaneous biological signal recording”, Physiological Measurement, 26:83-97 (2005). [cited by applicant]
Radio Frequency Identification RFID, AIM Inc., White Paper, Document Version 1.2, 17 pages (2001). [cited by applicant]
Sorrells, “Passive RFID Basics”, Microchip Technology Inc., DS00680B, pp. 1-5 (1998). [cited by applicant]
Partial International Search Report mailed Jan. 9, 2023 in International Application No. PCT/US2022/043493. [cited by applicant]
Breton, et al., “Optimum Subcutaneous Glucose Sampling and Fourier Analysis of Continuous Glucose Monitors”, Journal of Diabetes Science and Technology, 2(3):495-500 (2008). [cited by applicant]
Declaration of Brian D. Gross, 150 pages (2023). [cited by applicant]
Declaration of Morten O. Jensen, Ph.D., Dr.Med, 67 pages (2023). [cited by applicant]
Dexcom, Inserting Sensor, Instructions for Use, Dexcom, Inc., 2 pages (2021). [cited by applicant]
DexcomG7, Operational Manual, User Guide, Dexcom, Inc., 179 pages (2022) (with an English Abstract). [cited by applicant]
DexcomG7, Receiver: Start Here, Operational Manual, Dexcom, Inc., 8 pages (2022). [cited by applicant]
DexcomG7, Start Here, Operational Manual, Dexcom, Inc. 9 pages (2022) (with an English Abstract). [cited by applicant]
U.S. Appl. No. 17/245,719, filed Apr. 30, 2021, 168 pages. [cited by applicant]
U.S. Appl. No. 17/411,154, filed Aug. 25, 2021, 54 pages. [cited by applicant]
U.S. Appl. No. 60/587,787, filed Jul. 13, 2004, 69 pages. [cited by applicant]
Medtronic MiniMed, Inc., Fact Sheet, Features and Benefits for the MiniMed Paradigm® Real-Time System—https://web.archive.org/web/20071030065834/http://www.medtronicdiabetes.com/pdf/dtc_features_glance.pdf, 7 pages (200… [cited by applicant]
Medtronic MiniMed, Inc., Features for the MiniMed Paradigm® Real-Time System, the Wayback Machine—http://www.medtronicdiabetes.com/products/insulinpumps/features/index.html, 3 pages (2007) and Affidavit of Nathaniel E F… [cited by applicant]
Medtronic MiniMed, Inc., Frequently Asked Questions About the MiniMed Paradigm Real-Time System, the Wayback Machine—https://web.archive.org/web/20071023121607/http://www.medtronicdiabetes.com/product s/insulinpumps/fea… [cited by applicant]
Medtronic MiniMed, Inc., Request Information for the MiniMed Paradigm® Real-Time Insulin Pump and Continuous Glucose Monitoring System, the Wayback Machine—https://web.archive.org/web/20071009144413/http://www.medtronic… [cited by applicant]
Microchip, microID® 13.56 MHz RFID, System Design Guide, Microchip Technology Inc., 214 pages (2004). [cited by applicant]
Pantelopoulos, et al., “A Survey on Wearable Biosensor Systems for Health Monitoring”, 2008 30 [cited by applicant]
The MiniMed Paradigm® Insulin Pump and Continuous Glucose Monitoring System, Sensor Features User Guide, Paradigm® 522 and 722 Sensor Features, Medtronic MiniMed, 76 pages (2006) and Affidavit of Nathaniel E Frank-White… [cited by applicant]
United States Patent and Trademark Office, Before the Patent Trial and Appeal Board, [cited by applicant]
United States Patent and Trademark Office, Before the Patent Trial and Appeal Board, [cited by applicant]
United States Patent and Trademark Office, Before the Patent Trial and Appeal Board, [cited by applicant]
United States Patent and Trademark Office, Before the Patent Trial and Appeal Board, [cited by applicant]
Chuang et al., “Pilot Studies of Transdermal Continuous Glucose Measurement in Outpatient Diabetic Patients and in Patients during and after Cardiac Surgery,” Journal of Diabetes Science and Technology, 595-602 (2008). [cited by applicant]
Exhibit B-22.pdf—Opponent's Written Response in Opposition of EP 3 730 045, Sep. 27, 2023, 43 pages. [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, Dept of Health & Human Services, Food and Drug Administration, Mar. 12, 2008, 8 pages. [cited by applicant]
McCartney et al., “In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring,” BMJ, vol. 319, 4 pages (1999). [cited by applicant]
Townsend et al., “Getting Started with Bluetooth Low Energy—Tools and Techniques for Low-Power Networking,” O'Reilly Media, Inc., 180 pages (2014). [cited by applicant]
Wang et al. “A Feasible IMD Communication Protocol: Security without Obscurity,” School of Engineering and Computing Sciences, NYIT Research Experience for Undergraduates (REU), May 26-Jul. 30, 2015, 1 page. [cited by applicant]
Bluetooth Specification, Encryption and Authentication Overview, vol. 6, Version 4.0, page (2010). [cited by applicant]
Cornelius, “Usable Security for Wireless Body-Area Networks,” Dartmouth College PhD Dissertations. 42 (2013). [cited by applicant]
Cunningham et al., “In Vivo Glucose Sensing,” Wiley & Sons (2010). [cited by applicant]
Diallo et al., “A Secure Authentication Scheme for Bluetooth Connection,” 5th International Conference on Computer & Communication Engineering, DOI 10.1109/ICCCE.2014.29, 60-63 (2014). [cited by applicant]
Ellmerer et al., “Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion,” Am. J. Physiol. Endocrinol. Metab., 278: E352-E356 (2000). [cited by applicant]
Finkenzeller, “RFID Handbook: Fundamentals and Applications in Contactless Smart Cards, Radio Frequency Identification and Near-Field Communication”, Third Edition, 4 pages (2010). [cited by applicant]
German Infringement Complaint (2021) with English Abstract. [cited by applicant]
German Infringement Complaint Service addressed to Dexcom Deutschland GmbH (2021). [cited by applicant]
Guardian® Real-Time, Continuous Glucose Monitoring System, User Guide, Medtronic MiniMed, Inc., 181 pages (2006). [cited by applicant]
Guardian® RT, Continuous Glucose Monitoring System, Ref MMT-7900, User Guide, Medtronic MiniMed, 128 pages (2005). [cited by applicant]
Guder et al., “Samples: From the Patient to the Laboratory, the impact of preanalytical variables on the quality of laboratory results,” Wiley-Vch GmbH & Co. KGaA (2003). [cited by applicant]
Higson et al., “Biosensors: a viable monitoring technology?” Med. & Biol. Eng. & Comput., 32, 601-609 (1994). [cited by applicant]
Mohanty et al., Biosensors: A tutorial review, IEEE Potentials, 35-40 (2006). [cited by applicant]
Near Field Communication (NFC) Technology and Measurements, White Paper, Rohde & Schwarz, 18 pages (2011). [cited by applicant]
Near Field Communication (NFC) Technology and Measurements, White Paper, Rohde & Schwarz, 1 page (2011). [cited by applicant]
Padgette et al., “Guide to Bluetooth Security, Recommendations of the National Institute of Standards and Technology,” Nist, U.S. Dept. of Commerce, Special Publication 800-121 Revision 1 (2012). [cited by applicant]
Rivest et al., “A Method for Obtaining Digital Signatures and Public-Key Cryptosystems,” MIT, 15 pages (1977). [cited by applicant]
Schaupp et al., “Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion,” E401-E408, Downloaded from journals.physiology.org/journal/ajpendo (092.040.147.197) on Oct. 4, 2021. [cited by applicant]
Seymour et al., Bluetooth Master/Slave Communications and Sniff/Sniff Sub-rating Modes White Paper, Aug. 14, 2008. [cited by applicant]
Sola-Gazagnes, et al., “Emergent technologies applied to diabetes: What do we need to integrate continuous glucose monitoring into daily practice? Where the long-term use of continuous glucose monitoring stands in 2011”… [cited by applicant]
Specification of the Bluetooth System, Experience More, Specification vol. 0, Covered Core Package Version: 4.0, 2302 pages (2010). [cited by applicant]
Specification of the Bluetooth System, Experience More, Specification vol. 0, Covered Core Package Version: 4.0, 89 pages (2010). [cited by applicant]
Specification of the Bluetooth System, Master Table of Contents & Compliance Requirements, Version 4.2 (2014). [cited by applicant]
Specification of the Bluetooth System, Master Table of Contents & Compliance Requirements, Version 4.1 (2013). [cited by applicant]
Stallings, “Cryptography and Network Security, Principles and Practice,” 5th Ed., Prentice Hall (2011). [cited by applicant]
Strickland et al., “Continuous Glucose Monitoring Profile Bluetooth® Profile Specification,” Interest Group, v1.0.1 (2015). [cited by applicant]
The New Shorter Oxford English Dictionary, p. 50 (1993). [cited by applicant]
Townsend et al., “Getting Started with Bluetooth Low Energy,” O'Reilly (2014). [cited by applicant]
Wikipedia, “Analyte” retrieved from https://en.wikipedia.org/w/index.php?title=Analyte&oldid=527866671 (2012). [cited by applicant]
Wikipedia, “In vivo” retrieved from https://en.wikipedia.org/w/index.php?title=In_vivo&oldid=524960105 (2012). [cited by applicant]
Wikipedia page for “Challenge-response authentication” retrieved from https://en.wikipedia.org/w/index.php?title=Challenge-response authentication&oldid=567947229 (2013). [cited by applicant]
Wikipedia, Digital Signature, 10 pages retrieved from https://en.wikipedia.org/wiki/Digital_signature (2021). [cited by applicant]
Wikipedia page for “RSA (cryptosystem)” retrieved from https://en.wikipedia.org/w/index.php?title=RSA_(cryptosystem)&oldid=582212268, 17 pages retrieved from https://en.wikipedia.org/wiki/RSA_(cryptosystem) (2021). [cited by applicant]
Wikipedia page for “Bluetooth” retrieved from https://en.wikipedia.org/w/index.php?title=Bluetooth&oldid=744565671, 25 pages retrieved from https://en.wikipedia.org/wiki/Bluetooth (2022). [cited by applicant]
Wikipedia page for “Bluetooth Low Energy” retrieved from https://en.wikipedia.org/w/index.php?title=Bluetooth_Low_Energy&oldid=744163272, 11 pages retrieved from https://en.wikipedia.org/wiki/Bluetooth_Low_Energy (2022). [cited by applicant]
Wikipedia, “Near-field communication” retrieved from https://en.wikipedia.org/w/index.php?title=Near-field_communication&oldid=525308529 (2012). [cited by applicant]
International Search Report and Written Opinion mailed Mar. 30, 2023 corresponding to International Patent Application No. PCT/US2022/043493. [cited by applicant]
Zendehdel Ghazale Amel Gamel@UNB CA et al: “Automated Security Assessment Framework for Wearable BLE-enabled Health Monitoring Devices,” ACM Transactions on Internet Technology, ACM, New York, NY, US, vol. 22, No. 1, Se… [cited by applicant]
Buckingham et al., “Real-time continuous glucose monitoring,” Current Opinion in Endocrinology, Diabetes & Obesity, 288-295 (2007)—20 pages Appendix I. [cited by applicant]
Buckingham, “Clinical Overview of Continuous Glucose Monitoring,” Journal of Diabetes Science and Technology, vol. 2, Issue 2, 300-306 (2008)—26 pages Appendix J. [cited by applicant]
Diabetes Forecast, “Continuous Glucose Monitors for Kids,” Practical Living, 1 page (Aug. 2007). [cited by applicant]
Diabetes Forecast, “Continuous Glucose Monitors for Kids,” Practical Living, 10 pages (Aug. 2007). [cited by applicant]
File History of U.S. Pat. No. 10,194,844, issued Feb. 5, 2019, 151 pages. [cited by applicant]
File History of U.S. Pat. No. 11,013,431, issued May 25, 2021, 212 pages. [cited by applicant]
File History of U.S. Pat. No. 11,116,431, issued Sep. 14, 2021, 168 pages. [cited by applicant]
File History of U.S. Pat. No. 8,483,967, issued Jul. 9, 2013, 140 pages. [cited by applicant]
File History of U.S. Pat. No. 9,310,230, issued Apr. 12, 2016, 214 pages. [cited by applicant]
File History of U.S. Appl. No. 15/651,310, filed Oct. 4, 2019, 442 pages. [cited by applicant]
Medtronic, The MiniMed Paradigm® Real-Time Insulin Pump and Continuous Glucose Monitoring System, Sensor Features User Guide, https://web.archive.org/web/20071028164026/http://www.medtronicdiabetes.com/pdf/x22_sensor_fe… [cited by applicant]
NFC Forum Bluetooth Special Interest Group, Bluetooth® Secure Simple Pairing Using NFC, 39 pages (2014). [cited by applicant]
Omre, Bluetooth Low Energy: Wireless Connectivity for Medical Monitoring, Journal of Diabetes Science and Technology, vol. 4, No. 2, pp. 457-463 (2010). [cited by applicant]
Premarket Approval (PMA), Paradigm Real Time System, FDA, P980032, 3 pages, Apr. 7, 2006. [cited by applicant]
Specification vol. 0, Specification of the Bluetooth System, Experience More, Master Table of Contents & Compliance Requirements, 134 pages (2010). [cited by applicant]
Specification vol. 0, Specification of the Bluetooth System, Wireless connections made easy, Master Table of Contents & Compliance Requirements, 92 pages (2003). [cited by applicant]
Strömmer, et al., Application of Near Field Communication for Health Monitoring in Daily Life, Proceedings of the 28 [cited by applicant]
U.S. Appl. No. 15/651,310, filed Oct. 4, 2019, 442 pages. [cited by applicant]
WaybackMachine, Medtronic, [cited by applicant]
WaybackMachine, Medtronic, [cited by applicant]
WaybackMachine, Medtronic, [cited by applicant]
WaybackMachine, Medtronic, [cited by applicant]
WaybackMachine, Medtronic, [cited by applicant]
WaybackMachine, Medtronic, [cited by applicant]
Zhang, et al., Bluetooth Low Energy for Wearable Sensor-based Healthcare Systems, 2014 Health Innovations and Point-of-Care Technologies Conference, pp. 251-254 (2014). [cited by applicant]
Bluetooth Specification, Version 4.0, 2,303 pages (2010). [cited by applicant]
Bluetooth, Bluetooth Basics, Benefits of Bluetooth Technology, https://web.archive.org/web/20060611161103/http://www.bluetooth.com/Bluetooth/Learn/Basics/, 2006, 1 page. [cited by applicant]
Compare Specification—Apple iphone 6 vs. Apple iphone 6 Plus—https://www.gsmarena.com/compare.php3?idPhone1=6378&idPhone2=6665, 2 pages, Jan. 31, 2022. [cited by applicant]
Declaration of Nathaniel E. Frank-White, Nov. 9, 2023, 28 pages. [cited by applicant]
Dexcom Continuous Glucose Monitoring, Discover Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System, CGM unveils what no meter can . . . , Oct. 17, 2023, 18 pages. [cited by applicant]
Dexcom Continuous Glucose Monitoring, FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System, Aug. 24, 2015, 6 pages. [cited by applicant]
Dexcom G4 Platinum Pediatric, User's Guide Dexcom G4® Platinum (Pediatric) Continuous Glucose Monitoring System Received with Share™, 2015, 234 pages. [cited by applicant]
Dexcom G4® Platinum, Continuous Glucose Monitoring System, User's Guide, Dexcom, Inc., 161 pages (2015). [cited by applicant]
Dexcom G5 User Guide, Dexcom, Inc., 265 pages (2015). [cited by applicant]
Dexcom G5™ Mobile, Continuous Glucose Monitoring System, User Guide, Dexcom, Inc., 264 pages (2015). [cited by applicant]
Dexcom News Releases—FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System with Share—https://www.dexcom.com/en-us/news/fda-approves-dexcom-g4-platinum-continuous-glucose-monitoring-system-share, Dexcom, … [cited by applicant]
Dexcom Press Release—FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System—https://www.dexcom.com/news/1257506247-fda-approves-dexcom-g5®-mobile-continuous-glucose-monitoring-system, Dexcom, Inc., 4 pages,… [cited by applicant]
Encyclopedia Britannica, Science & Tech, Bluetooth Definition, 5 pages, (Oct. 14, 2023). [cited by applicant]
Excerpts from the “German Health Report Diabetes 2023” of the German Diabetes Society, 14 pages (2022) (with an English Abstract). [cited by applicant]
FDA U.S. Food & Drug Administration, Premarket Approval (PMA), Sep. 16, 2006, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=388585, 4 pages. [cited by applicant]
Federal Communications Commission Office of Engineering and Technology Policy and Rules Division, FCC Online Table of Frequency Allocations, Revised on Jul. 1, 2022, 180 pages. [cited by applicant]
Ferro, et al., “Bluetooth and Wi-fi Wireless Protocols: A Survey and a Comparison”, IEEE Wireless Communications, pp. 1-24 (2004). [cited by applicant]
Ferro, et al., “Bluetooth and Wi-fi Wireless Protocols: A Survey and a Comparison”, IEEE Wireless Communications, 12(1):12-26 (2005). [cited by applicant]
FreeStyle Libre Flash Glucose Monitoring System, User's Manual, Abbott Diabetes Care Ltd., 124 pages (2014). [cited by applicant]
Hamblen, “A short history of NFC: Where Near Field Communication has come from.”, 2 pages, Dec. 19, 2012. [cited by applicant]
IPhone User Guide for iOS 8.4 Software, 2015, 196 pages. [cited by applicant]
Klueh, et al., “Inflammation and Glucose Sensors: Use of Dexamethasone to Extend Glucose Sensor Function and Life Span in Vivo”, Journal of Diabetes Science and Technology, 1(4):496-504 (2007). [cited by applicant]
Medtronic, CareLink Personal Therapy Management Software for Diabetes, 2007, 20 pages. [cited by applicant]
Memorandum Opinion, [cited by applicant]
Press Coverage of FreeStyle Libre launch, Antonia Giese, retrieved from https://www.bild.de/ratgeber/gesundheit/diabetes/hightech-zucker-sensor-diabetes-test-freestyle-libre-flash-37732134.bild.html, 8 pages Sep. 20, 20… [cited by applicant]
Seven STS® Continuous Glucose Monitoring System User's Guide, 2007, 74 pages. [cited by applicant]
Specification of the Bluetooth System, Experience More, Specification vol. 0, Covered Core Package Version: 4.0, 41 pages (2010). [cited by applicant]
Specification of the Samsung Galaxy Alpha, Samsung Newsroom Deutschland—http://www.samsung.de/galaxyalpha, 7 pages, Aug. 13, 2014 (with an English Abstract). [cited by applicant]
Wikipedia, the Free Encyclopedia, “Continuous glucose monitor”, retrieved from https://en.wikipedia.org/w/index.php?title=Continuous_glucose_monitor&oldid=1180606331, 10 pages (Oct. 1, 2023). [cited by applicant]
Wikipedia, the Free Encyclopedia, “Radio-frequency identification”, retrieved from https://en.wikipedia.org/wiki/Radio-frequency_identification, 30 pages (Oct. 23, 2023). [cited by applicant]
U.S. Appl. No. 60/587,787, filed Jul. 13, 2004, Brister et al. [cited by applicant]
CareLinkTMUsb, User Guide Medtronic MiniMed, 11pages (2007). [cited by applicant]
Ocean Systems Test and Evaluation Program, Data Communications Plan, NOAA, U.S. Department of Commerce, National Ocean Service Center for Operational Oceanographic Products and Services, 199 pages, May 2006. [cited by applicant]
The MiniMed Paradign Real-Time System: A Practical Guide to Continuous Glucose Monitoring, 18 pages (2006). [cited by applicant]
The MiniMed Paradign Real-Time Insulin Pump and Continuous Glucose Monitoring System, Fact Sheet, 2 pages (2006). [cited by applicant]
The MiniMed Paradign Real-Time Insulin Pump and Continuous Glucose Monitoring System, 522 and 722 Insulin Pumps User Guide, 262 pages (2008). [cited by applicant]
Cited By (1)
US 1,120,957